An oncogenic enhancer promotes melanoma progression via regulating ETV4 expression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
An oncogenic enhancer promotes melanoma progression via regulating ETV4 expression ; volume:22 ; number:1 ; day:7 ; month:6 ; year:2024 ; pages:1-15 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (7.6.2024), 1-15, 12.2024
- Creator
-
Zhang, Junyou
Wang, Qilin
Qi, Sihan
Duan, Yingying
Liu, Zhaoshuo
Liu, Jiaxin
Zhang, Ziyi
Li, Chunyan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05356-8
- URN
-
urn:nbn:de:101:1-2408151255147.844442963950
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Junyou
- Wang, Qilin
- Qi, Sihan
- Duan, Yingying
- Liu, Zhaoshuo
- Liu, Jiaxin
- Zhang, Ziyi
- Li, Chunyan
- SpringerLink (Online service)
Other Objects (12)
ERK5 is activated by oncogenic BRAF and promotes melanoma growth
IRE1α-XBP1 pathway promotes melanoma progression by regulating IL-6/STAT3 signaling
Long non-coding RNA CASC15 promotes melanoma progression by epigenetically regulating PDCD4
Shared enhancer gene regulatory networks between wound and oncogenic programs
Super-enhancer-associated long noncoding RNA AC005592.2 promotes tumor progression by regulating OLFM4 in colorectal cancer
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
The MAPK pathway as an apoptosis enhancer in melanoma
Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis
TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway
Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota
Oncogenic KRAS promotes malignant brain tumors in zebrafish
Landscape of enhancer disruption and functional screen in melanoma cells
ERK5 is activated by oncogenic BRAF and promotes melanoma growth
IRE1α-XBP1 pathway promotes melanoma progression by regulating IL-6/STAT3 signaling
Long non-coding RNA CASC15 promotes melanoma progression by epigenetically regulating PDCD4
Shared enhancer gene regulatory networks between wound and oncogenic programs
Super-enhancer-associated long noncoding RNA AC005592.2 promotes tumor progression by regulating OLFM4 in colorectal cancer
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
The MAPK pathway as an apoptosis enhancer in melanoma
Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis
TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway
Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota
Oncogenic KRAS promotes malignant brain tumors in zebrafish
Landscape of enhancer disruption and functional screen in melanoma cells
ERK5 is activated by oncogenic BRAF and promotes melanoma growth
IRE1α-XBP1 pathway promotes melanoma progression by regulating IL-6/STAT3 signaling
Long non-coding RNA CASC15 promotes melanoma progression by epigenetically regulating PDCD4
Shared enhancer gene regulatory networks between wound and oncogenic programs
Super-enhancer-associated long noncoding RNA AC005592.2 promotes tumor progression by regulating OLFM4 in colorectal cancer
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
The MAPK pathway as an apoptosis enhancer in melanoma
Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis
TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway
Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota
Oncogenic KRAS promotes malignant brain tumors in zebrafish